Jiangsu Hengrui reported CNY2.58B in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Cspc Pharmaceutical CNY 1.48B 927.97M Mar/2025
Kangmei Pharma CNY 8.4M 110.17K Jun/2025
Sh Fosun Pharma CNY 937.21M 172.45M Jun/2025
Sh Pharmaceutical CNY 3.13B 1.79B Jun/2025
Sino Biopharmaceutical CNY 482.67M 2.53B Dec/2024
Wuxi Apptec CNY 4.91B 1.24B Jun/2025
Zz Pientze Pharmaceu 442.53M 557.25M Jun/2025